WASHINGTON, DC
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)BIOTECHNOLOGY INSTITUTE, founded in 2002, is a small nonprofit in the Diseases & Disorders sector that reported $776K in total revenue in fiscal year 2021. Revenue surged 82% from the prior year, signaling strong growth momentum. The organization ran a surplus of $264K, a strong 34% operating margin.
SEE PART III, LINE 1.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2021 | 2020 | Change | |
|---|---|---|---|
| Revenue | $775,500 | $425,000 | +0.8% |
| Expenses | $511,266 | $303,325 | +0.7% |
| Net Income | $264,234 | $121,675 | +1.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JAMES GREENWOOD | CHAIRMAN | 4.00 |
Officer
Director
|
$0 | $0 | $0 |
| HEIDI JARVIS GRIMES | TREASURER | 4.00 |
Officer
Director
|
$0 | $0 | $0 |
| LECIA BROWN | BOARD MEMBER | 4.00 |
Director
|
$0 | $0 | $0 |
| LAWRENCE MAHAN | PRESIDENT | 30.00 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2021 | $775,500 | $511,266 | $332,875 | $264,234 |
| 2020 | $425,000 | $303,325 | $92,812 | $121,675 |
| 2019 | $550,000 | $492,465 | $105,674 | $57,535 |
| 2018 | $500,000 | $537,538 | $68,180 | $-37,538 |
Compare BIOTECHNOLOGY INSTITUTE with other nonprofits in District of Columbia and across the country.